Nav: Home

Intermittent fasting protects mice from type 2 diabetes

July 09, 2019

Every-other-day fasting substantially reduces the likelihood of developing type 2 diabetes in mice eating a fat-rich diet, according to new research out of the German Institute of Human Nutrition Potsdam-Rehbruecke. These findings, presented this week at the annual meeting of the Society for the Study of Ingestive Behavior in Utrecht, Netherlands, suggest that periodic fasting can reduce fat accumulation in the pancreas and, in turn, prevent the onset of type 2 diabetes. "We observed that pancreatic fat cells directly affect islet insulin secretion and that this can be altered by eating patterns" said Dr. Mandy Stadion, a post-doctoral research fellow who led this study.

"It is well known that a fatty liver promotes the development of type 2 diabetes and that intermittent fasting improves insulin sensitivity by reducing liver fat in mice and men," explained Professor Annette Schürmann, head of the Department Experimental Diabetology at the German Institute of Human Nutrition and senior author of the study. "However, little is known about the formation of fat cells in the pancreas during obesity, their detailed impact on islet-cell function and whether intermittent fasting can prevent a fatty pancreas."

For these studies the researchers provided one group of diabetes-prone mice with unlimited access to a high-fat diet. These mice were subjected to food restriction every other day (intermittent fasting). Compared to the control condition, intermittent fasting resulted in remarkably reduced pancreatic fat - similar to levels of diabetes-resistant mice - as well as in lower blood sugar levels and improved islet-cell function.

"We believe that the elevated insulin secretion of pancreatic islet cells, particularly from diabetes-prone mice, initiates a more rapid loss of function and finally islet cell-death,"explaned Schürmann. And while this loss of function ultimately contributes to the development of type 2 diabetes, the researchers are optimistic the finding that intermittent fasting can prevent the fat accumulation that leads to increased insulin may reveal a new path forward in the therapeutic prevention and treatment of diabetes.
-end-
Research citation: Intermittent fasting reduces pancreatic fat and prevents type 2 diabetes in mice
Mandy Stadion, Charline Quiclet, Anneke Gässler, Christian Baumeier, Tim J. Schulz, Annette Schürmann
German Institute for Human Nutrition Potsdam-Rehbruecke, Potsdam, Germany; German Center for Diabetes Research (DZD) München-Neuherberg, Germany
Presented July 2019, Society for the Study of Ingestive Behavior, Utrecht, Netherlands

Contact:
Mandy Stadion, PhD
stadion@dife.de
+49 (0) 33200 88 2140

@Leibniz_DIfE

Society for the Study of Ingestive Behavior

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
More Diabetes News and Diabetes Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#542 Climate Doomsday
Have you heard? Climate change. We did it. And it's bad. It's going to be worse. We are already suffering the effects of it in many ways. How should we TALK about the dangers we are facing, though? Should we get people good and scared? Or give them hope? Or both? Host Bethany Brookshire talks with David Wallace-Wells and Sheril Kirschenbaum to find out. This episode is hosted by Bethany Brookshire, science writer from Science News. Related links: Why Climate Disasters Might Not Boost Public Engagement on Climate Change on The New York Times by Andrew Revkin The other kind...
Now Playing: Radiolab

An Announcement from Radiolab